Does TRIPTORELIN Cause Off label use? 545 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 545 reports of Off label use have been filed in association with TRIPTORELIN (TRIPTODUR). This represents 10.1% of all adverse event reports for TRIPTORELIN.
545
Reports of Off label use with TRIPTORELIN
10.1%
of all TRIPTORELIN reports
13
Deaths
67
Hospitalizations
How Dangerous Is Off label use From TRIPTORELIN?
Of the 545 reports, 13 (2.4%) resulted in death, 67 (12.3%) required hospitalization, and 5 (0.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIPTORELIN. However, 545 reports have been filed with the FAERS database.
What Other Side Effects Does TRIPTORELIN Cause?
Death (362)
Ovarian hyperstimulation syndrome (356)
Needle issue (242)
Disease progression (203)
Product dose omission issue (178)
Drug ineffective (175)
Weight increased (167)
Hot flush (153)
Headache (145)
Injection site pain (138)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TRIPTORELIN Alternatives Have Lower Off label use Risk?
TRIPTORELIN vs TRISODIUM
TRIPTORELIN vs TROFINETIDE
TRIPTORELIN vs TROFOSFAMIDE
TRIPTORELIN vs TROPATEPINE
TRIPTORELIN vs TROPICAMIDE